Contraceptive advice for women receiving enzyme-inducing antiepileptic drugs and those on lamotrigine

Epilepsy is a neurological disorder that requires careful management, including the consideration of how antiepileptic drugs (AEDs) interact with other medications, such as contraceptives. A significant aspect of managing epilepsy, particularly in women of childbearing age, involves understanding the implications of AEDs on contraceptive efficacy and choice.

The interaction between AEDs and contraceptives is primarily due to the enzyme-inducing properties of certain AEDs. Enzyme-inducing AEDs increase the metabolic activity in the liver, leading to a faster breakdown of contraceptive hormones. This can significantly reduce the effectiveness of hormonal contraceptives, thereby increasing the risk of unintended pregnancy.

Examples of enzyme-inducing AEDs include:

• Phenytoin
• Carbamazepine
• Phenobarbital
• Primidone

These AEDs are known to reduce the levels of estrogen and progestogen in the body due to increased enzyme activity, thus diminishing the contraceptive effectiveness of pills, patches, vaginal rings, and implants. Women on these medications are often advised to consider alternative contraceptive methods, such as medroxyprogesterone acetate injections or intrauterine devices (IUDs), which are not affected by these drug interactions.